Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1960 Jan 31;111(2):217–234. doi: 10.1084/jem.111.2.217

RELATION OF A β1-GLYCOPROTEIN OF HUMAN SERUM TO THE COMPLEMENT SYSTEM

H J Müller-Eberhard 1, U Nilsson 1
PMCID: PMC2137252  PMID: 19867170

Abstract

The protein of human serum, tentatively designated β1C-globulin, was shown to possess serological activity and to be related to the complement system. Another serum protein (β1A-globulin) was identified as the inactivated form of β1C-globulin. Incubation of fresh serum with various immune precipitates or with soluble γ-globulin aggregates at 37°C. resulted in the removal of β1C-globulin. Treatment of fresh serum with zymosan at 17 and 37°C. had a similar effect. In both instances β1C-globulin was removed from serum, apparently by conversion to β1A-globulin. However, isolated β1C-globulin did not react with immune precipitates or zymosan, nor did β1C-globulin of serum previously heated at 56°C. Highly purified β1C-globulin was tested for complement component activity by means of the usual reagents. All of the preparations examined were found to reconstitute the hemolytic activity of guinea pig R3. However, they failed to reconstitute R3 obtained from human serum. Isolated β1A-globulin was found to be inactive in all systems. When isolated β1C-globulin in either phosphate or in borate buffer was stored at 37°C., the activity detected by means of guinea pig R3 declined within 6 days to 20 to 30 per cent of its original value. As the activity decreased, β1C-globulin was gradually converted to β1A-globulin. Addition of β1C-globulin to a limited complement system (human C') caused an increase of both initial velocity and final degree of hemolysis. Although β1C-globulin did not cause lysis of EAC'1, 4, 2, it fully prevented the otherwise rapid decay of EAC'1, 4, 2 at 37°C., and so presumably interacted with this complex.

Full Text

The Full Text of this article is available as a PDF (951.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMIRAIAN K., PLESCIA O. J., CAVALLO G., HEIDELBERGER M. Complex nature of the step in immune hemolysis involving third component of complement. Science. 1958 Jan 31;127(3292):239–240. doi: 10.1126/science.127.3292.239. [DOI] [PubMed] [Google Scholar]
  2. ARDAY F. R., PILLEMER L., LEPOW I. H. The properdin system and immunity. VIII. Studies on the purification and properties of the third component of human complement. J Immunol. 1959 May;82(5):458–466. [PubMed] [Google Scholar]
  3. LEON M. A. Quantitative studies of the properdin-complement system. III. Kinetics of the reaction between C'3 and the properdin-zymosan complex. J Immunol. 1958 Jul;81(1):23–28. [PubMed] [Google Scholar]
  4. LEPOW I. H., RATNOFF O. D., ROSEN F. S., PILLEMER L. Observations on a pro-esterase associated with partially purified first component of human complement (C'1). Proc Soc Exp Biol Med. 1956 May;92(1):32–37. doi: 10.3181/00379727-92-22376. [DOI] [PubMed] [Google Scholar]
  5. LEVINE L., MAYER M. M., RAPP H. J. Kinetic studies on immune hemolysis. VI. Resolution of the C'y reaction step into two successive processes involving C'2 and C'3. J Immunol. 1954 Dec;73(6):435–442. [PubMed] [Google Scholar]
  6. MAYER M. M., LEVINE L., RAPP H. J., MARUCCI A. A. Kinetic studies on immune hemolysis. VII. Decay of EAC'1, 4, 2, fixation of C'3, and other factors influencing the hemolytic action of complement. J Immunol. 1954 Dec;73(6):443–454. [PubMed] [Google Scholar]
  7. MAYER M. M. Studies on the mechanism of hemolysis by antibody and complement. Prog Allergy. 1958;5:215–270. [PubMed] [Google Scholar]
  8. MULLER-EBERHARD H. J., NILSSON U., ARONSSON T. Isolation and characterization of two beta1-glycoproteins of human serum. J Exp Med. 1960 Feb 1;111:201–215. doi: 10.1084/jem.111.2.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. NELSON R. A., Jr An alternative mechanism for the properdin system. J Exp Med. 1958 Oct 1;108(4):515–535. doi: 10.1084/jem.108.4.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. PILLEMER L., BLUM L., LEPOW I. H., ROSS O. A., TODD E. W., WARDLAW A. C. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 1954 Aug 20;120(3112):279–285. doi: 10.1126/science.120.3112.279. [DOI] [PubMed] [Google Scholar]
  11. Pillemer L., Ecker E. E., Oncley J. L., Cohn E. J. THE PREPARATION AND PHYSICOCHEMICAL CHARACTERIZATION OF THE SERUM PROTEIN COMPONENTS OF COMPLEMENT. J Exp Med. 1941 Sep 30;74(4):297–308. doi: 10.1084/jem.74.4.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. RAPP H. J. Mechanism of immune hemolysis: recognition of two steps in the conversion of EAC' 1,4,2 to E. Science. 1958 Jan 31;127(3292):234–236. doi: 10.1126/science.127.3292.234-a. [DOI] [PubMed] [Google Scholar]
  13. RAPP H. J., SIMS M. R., BORSOS T. Separation of components of guinea pig complement by chromatography. Proc Soc Exp Biol Med. 1959 Apr;100(4):730–733. doi: 10.3181/00379727-100-24758. [DOI] [PubMed] [Google Scholar]
  14. RATNOFF O. D., LEPOW I. H. Some properties of an esterase derived from preparations of the first component of complement. J Exp Med. 1957 Aug 1;106(2):327–343. doi: 10.1084/jem.106.2.327. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES